⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SANG News
Sangoma Technologies Corporation Common Shares
Delisting of Securities from The Nasdaq Stock Market
globenewswire.com
MAXN
SANG
ADTX
PTNM
SPWR
NVVE
KVAC
Cell and Gene Therapies for Rare Disorders Poised for Breakthrough Growth Through 2036, Fueled by Innovation, Expanding Pipelines and Unmet Patient Needs
globenewswire.com
CSL
SANG
CAPR
SPRC
NVS
Global Huntington's Disease Treatment Market 2026-2031 - Advancements in Novel Therapeutics to Drive Growth
globenewswire.com
PFE
TEVA
NBIX
ALNY
IONS
NVS
QURE
SANG
PTC
WVE
Sangoma and Jazzware Partner to Improve Hotel Operations and Guest Experience with Integrated Hospitality Communications Solution
businesswire.com
SANG
Gene Editing Market to Reach US$30.5 Billion by 2033 as Precision Medicine and CRISPR Innovation Accelerate Growth - Persistence Market Research
prnewswire.com
CRSP
NTLA
TMO
SANG
Gene Editing Therapeutics: Transforming Biopharmaceuticals with 12.5% CAGR Growth Forecast
globenewswire.com
CRSP
NTLA
EDIT
BEAM
SANG
CELC
CRBU
PRME
Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
RAPT
SANG
INCY
ABBV
ARCT
AMGN
CHKP
PFE
LLY
SCLX
SNY
UCB
BIIB
NVS
VTRS
BMY
ABSI
ALEC
GSK
IONS
CLNN
ANNX
MED
GAM
VRTX
EXC
BLRX
Sangoma Announces CFO Transition: Larry Stock to Retire June 30; Adrian Back Named Interim CFO; Board Commences Search for Permanent Successor
businesswire.com
SANG
Carrier-Grade VoIP Platforms and Session Border Controller Infrastructure Research Report 2026: A $413.36 Billion Market by 2032 Featuring Nokia, Alianza, NetSapiens, Telnyx, 46 Labs, Sangoma, Ooma
globenewswire.com
NOK
SANG
OOMA
Sangoma Announces Third Quarter Fiscal 2026 Results
businesswire.com
SANG